Browse our anti-SNCA (SNCA) Antibodies

On are 753 Synuclein, alpha (SNCA) Antibodies from 40 different suppliers available. Additionally we are shipping SNCA Proteins (75) and SNCA Kits (70) and many more products for this protein. A total of 923 SNCA products are currently listed.
alphaSYN, LOC619283, MGC64356, NACP, PARK1, PARK4, PD1, snca
list all antibodies Gene Name GeneID UniProt
SNCA 20617 O55042
SNCA 6622 P37840
SNCA 29219 P37377

Most Popular Reactivities for anti-SNCA (SNCA) Antibodies

anti-Mouse (Murine) SNCA Antibodies:

anti-Human SNCA Antibodies:

anti-Rat (Rattus) SNCA Antibodies:

All available anti-SNCA Antibodies

Go to our pre-filtered search.

More Antibodies against SNCA Interaction Partners

Xenopus laevis Synuclein, alpha (SNCA) interaction partners

  1. study examined the spatial and temporal expression patterns of three synuclein genes (snca, sncbb, sncg) during embryogenesis

Mouse (Murine) Synuclein, alpha (SNCA) interaction partners

  1. The findings of this study indicated a functional role of alpha-synuclein in early experimental autoimmune encephalomyelitis by increasing Th1 (show HAND1 Antibodies) cell-mediated immune response.

  2. These data show that neurodegenerative processes associated with lysosomal dysfunction may be presynaptically initiated by a concomitant reduction in alpha-synuclein and CSPalpha levels at nerve terminals.

  3. Data suggest that endocytosis is the principal mechanism by which proteopathic alpha-synuclein aggregates are internalized in primary hippocampal neurons in culture; aggregates are rapidly trafficked along endosomal/lysosomal pathway, where most of the material remains for days as proposed in neurodegenerative synucleinopathies.

  4. LRRK2 (show LRRK2 Antibodies) negatively regulates the clearance of alphaSYN accompanied by down-regulation of the endocytosis pathway; LRRK2 (show LRRK2 Antibodies) in microglia may function as the offending molecule responsible for neurodegeneration, in terms of down-regulation of alphaSYN clearance.

  5. sideroflexin 3 (SFXN3 (show SFXN3 Antibodies)) was found to be a mitochondrial protein (show COX6B2 Antibodies) localized to the inner mitochondrial membrane.

  6. The ability of monomeric alpha-synuclein to enhance ATP synthase efficiency under physiological conditions may be of importance when alpha-synuclein undergoes the misfolding and aggregation

  7. Rab7 (show RAB7A Antibodies) accumulated in GCase (show GBA Antibodies) deficient cells, supporting the notion that lysosomal recycling is impaired. Since recombinant GCase (show GBA Antibodies) can reverse ALR (show GFER Antibodies) impairment, we anticipate that strategies to restore GCase (show GBA Antibodies) activity in the brains of both sporadic patients with PD and those with GBA1 (show GBA Antibodies) mutations will improve autophagy lysosomal pathway, preventing the accumulation of a-synuclein and spread of pathology.

  8. Study showed that apoptosis is an important form of cellular degeneration in lipopolysaccharide (LPS (show TLR4 Antibodies)-sensitized hypoxic-ischemic (HI) injury in the immature brain. Loss of PINK1 (show PINK1 Antibodies) can protect the immature brain against cell apoptosis induced by LPS (show TLR4 Antibodies)-sensitized HI injury. Moreover, alpha-Syn plays a neuroprotective role in LPS (show TLR4 Antibodies)-sensitized HI brain damage in PINK1 (show PINK1 Antibodies)-knockout neonatal mice

  9. Genetic manipulation of sirtuin 2 (show SIRT2 Antibodies) levels in vitro and in vivo modulates the levels of alpha-synuclein acetylation, its aggregation, and autophagy.

  10. These results indicate that fragmented amyloid-like aggregates of short alpha-syn fibrils are the key pathogenic seeds that trigger prion (show PRNP Antibodies)-like conversion.

Human Synuclein, alpha (SNCA) interaction partners

  1. results indicated that the dismal prognosis of patients with HBsAg+ may be related to the high rate of PD1 (show PDCD1 Antibodies) expression. Thus, a targeted PD1 (show PDCD1 Antibodies) treatment strategy may improve the prognosis of HBsAg+ DLBCL patients

  2. PD-1 (show PDCD1 Antibodies) in osteosarcoma patients mediated follicular helper T cells suppression.

  3. Data show that cyclophilin 40 (CyP40) interacts with and dissolves amyloids forming proteins tau and alpha-synuclein aggregates.

  4. Phosphotyrosine 39 alpha-synuclein is a potential disease indicator for Parkinson disease and related alpha-synucleinopathies.

  5. Study suggests histones as prime candidates for one of the nuclear proaggregant factors involved in the formation of transmissible alpha-synuclein aggregates during neuron apoptosis.

  6. Study provides evidence that phosphorylated alpha-synuclein deposition is present in dermal nerve fibers in a subgroup of patients suffering from REM (show REM1 Antibodies) sleep behavior disorder, presumably representing prodromal Parkinson's disease.

  7. This review describes the major findings supporting the occurrence of alpha-synuclein pathology propagation in Parkinson's disease and discusses how this phenomenon could induce or contribute to synaptic injury and degeneration. [Review]

  8. This review evaluated major classes of molecular chaperones and their mechanisms relevant for preventing protein aggregation, specific case of alpha-synuclein aggregation. [review]

  9. Data suggest that endocytosis is the principal mechanism by which proteopathic alpha-synuclein aggregates are internalized in primary hippocampal neurons in culture; aggregates are rapidly trafficked along endosomal/lysosomal pathway, where most of the material remains for days as proposed in neurodegenerative synucleinopathies.

  10. Data suggest that endocytosis and lysosomal processing of proteopathic alpha-synuclein aggregates in neurons are consistent with models of neurodegeneration in synucleinopathies. [EDITORIAL]

Cow (Bovine) Synuclein, alpha (SNCA) interaction partners

  1. analysis of membrane curvature sensing by amphipathic helices using alpha-synuclein and annexin B12 (show TNFAIP1 Antibodies) [ANXB12]

  2. Immunocytochemistry shows alpha synuclein localized to the Golgi apparatus and vesicles of bovine adrenal medullary chromaffin cells, consistent with its putative role in vesicular function within synapses.

SNCA Antigen Profile

Antigen Summary

Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene.

Alternative names and synonyms associated with SNCA

  • synuclein, alpha (snca) antibody
  • alpha-synuclein (LOC619283) antibody
  • alpha-synuclein (LOC100359228) antibody
  • synuclein, alpha (Snca) antibody
  • synuclein, alpha (non A4 component of amyloid precursor) (SNCA) antibody
  • synuclein, alpha (non A4 component of amyloid precursor) (Snca) antibody
  • alphaSYN antibody
  • LOC619283 antibody
  • MGC64356 antibody
  • NACP antibody
  • PARK1 antibody
  • PARK4 antibody
  • PD1 antibody
  • snca antibody

Protein level used designations for anti-Synuclein, alpha (SNCA) Antibodies

synuclein, alpha , alpha-synuclein , alpha SYN , non-A beta component of AD amyloid , non-A4 component of amyloid , non A-beta component of AD amyloid , synuclein alpha-140 , alpha synuclein

380315 Xenopus laevis
619283 Takifugu rubripes
100359228 Oryctolagus cuniculus
20617 Mus musculus
6622 Homo sapiens
29219 Rattus norvegicus
641350 Sus scrofa
282857 Bos taurus
395393 Gallus gallus
100294604 Ovis aries
Selected quality suppliers for anti-SNCA (SNCA) Antibodies
Did you look for something else?